<html>
<head>PUBMED IDs for SLC21A6</head>
<body bgcolor='#C5F0F2'><h1>SLC21A6</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10779507/'>Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide.</a> April 26  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10838093/'>Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver.</a> June 6  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11477075/'>Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans.</a> July 31  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11483603/'>Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha.</a> August 3  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12130747/'>Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis.</a> July 20  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12196548/'>A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter.</a> August 28  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12490595/'>Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation.</a> December 20  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12601360/'>Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression.</a> February 26  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12811365/'>Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.</a> June 18  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14699511/'>Enterohepatic bile salt transporters in normal physiology and liver disease.</a> December 31  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14705859/'>Pathophysiological factors affecting CAR gene expression.</a> January 7  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15382119/'>Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance.</a> September 24  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15716364/'>Hepatic uptake of the novel antifungal agent caspofungin.</a> February 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17323126/'>Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.</a> February 27  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18334180/'>[[Inflammation and drug metabolism: NF-kappB and the CAR and PXR xeno-receptors].</a> March 13  2008<br></body></html>
